Compare SPRY & BOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SPRY | BOW |
|---|---|---|
| Founded | 2015 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 634.5M | 734.3M |
| IPO Year | 2020 | 2024 |
| Metric | SPRY | BOW |
|---|---|---|
| Price | $5.90 | $33.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $40.00 | $32.29 |
| AVG Volume (30 Days) | ★ 1.7M | 469.3K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.26 |
| EPS | N/A | ★ 0.96 |
| Revenue | $84,278,000.00 | ★ $551,589,000.00 |
| Revenue This Year | $87.40 | $21.31 |
| Revenue Next Year | $81.64 | $19.15 |
| P/E Ratio | ★ N/A | $34.99 |
| Revenue Growth | N/A | ★ 29.58 |
| 52 Week Low | $4.91 | $21.21 |
| 52 Week High | $13.15 | $35.07 |
| Indicator | SPRY | BOW |
|---|---|---|
| Relative Strength Index (RSI) | 47.54 | 61.63 |
| Support Level | $4.96 | $24.07 |
| Resistance Level | $6.58 | $35.07 |
| Average True Range (ATR) | 0.38 | 0.21 |
| MACD | 0.09 | -0.13 |
| Stochastic Oscillator | 61.08 | 38.46 |
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.
Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division, which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury, or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity, and hospitality segments, and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.